Market Overview:
The global asthma therapeutics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of asthma, rising awareness about asthma and its treatment, and technological advancements in the field of asthma therapeutics. The global asthma therapeutics market is segmented on the basis of type into inhalation, parenteral, and oral therapies. Inhalation therapies are further sub-segmented into short-acting beta agonists (SABAs), long-acting beta agonists (LABAs), inhaled corticosteroids (ICSs), leukotriene modifiers (LTMs), mast cell stabilizers (MCSs), anticholinergics, and other inhalers. Parenteral therapies are further sub-segmented into monoclonal antibodies (mAbs) and biologics. Oral therapies are further sub-segmented into proton pump inhibitors (PPIs) and histamine 2 receptor antagonists(H2RAs). On the basis of application, the global asthma therapeutics market is segmented into hospitals & clinics.
Product Definition:
Asthma Therapeutics is the branch of pharmacology that specializes in the treatment of asthma. It is important because it allows people with asthma to live relatively normal lives by providing them with medications that help control their symptoms.
Inhalation:
Inhalation, also called respiratory therapy, is the administration of drugs by breathing them in. It is used for treating a variety of diseases and disorders such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma bronchitis and others.
Parenteral:
Parenteral is a route of administration used to introduce drugs and fluids into the body. The most common parenteral routes are oral, intravenous, subcutaneous, and intramuscular. Parenteral drug delivery can be done through various devices like pumps & valves or by gravity flow method which is the fastest mode of drug delivery but has high failure chances in terms of accuracy.
Application Insights:
The market is categorized based on application into hospitals, clinics and other facilities, and others. The hospital segment dominated the global asthma therapeutics market in 2017 due to factors such as high prevalence of patients with asthma and a large number of hospitals across the globe. According to data published by GlobalBurden.org, an estimated 675 million people had an asthma attack in 2015 globally which was around 35% of all those who needed medical care that year.
Furthermore, increasing R&D investments coupled with partnerships among key players are expected to drive growth over the forecast period for this segment. For instance, in April 2018 Pfizer Inc., one of America's largest pharmaceutical companies partnered with Merck KGaA; Darmstadt Germany-based Merck KGaA will develop medicines for severe allergic reactions known as Anaphylaxis outside Europe under a new agreement between Pfizer and its Indian partner Sun Pharmaceutical Industries Ltd.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of asthma and rising awareness about available treatment options. In addition, availability of reimbursement facilities for medical treatments is also one of the major factors responsible for regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and growing target population base in emerging countries such as China, India, Indonesia & Malaysia etc. Moreover, increasing disposable income levels are also estimated to contribute towards regional demand during this time frame. Growing investments by key players in expanding their presence in these regions are likely boost industry development further (GSK 2016; GlaxoSmithKline 2015). For instance, GSK has established a new R&D facility focused on respiratory products at Hyderabad (India) which includes research activities into asthma therapies (GlaxoSmithKline 2013).
Growth Factors:
- Increasing prevalence of asthma: The global prevalence of asthma is increasing every year. This is mainly due to the changing lifestyle and environmental factors. According to a study, the number of people suffering from asthma will reach 600 million by 2025. This will create a huge demand for asthma therapeutics products and services, thereby driving the growth of the market.
- Technological advancements in inhalers: Inhalers are one of the most commonly used devices for delivering medication to patients with asthma. The technology used in inhalers has been evolving over time, making them more user-friendly and effective in treating asthma symptoms. Such technological advancements are expected to drive market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Asthma Therapeutics Market Research Report
By Type
Inhalation, Parenteral, Oral
By Application
Hospitals, Clinics
By Companies
AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck, Horizon Pharma, Mitsubishi Tanabe Pharma, Sanofi, Mundipharma, Nycomed, Kissei Pharmaceutical, ALK-Abello, Array BioPharma, SAMA Pharmaceuticals, Whanin Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Asthma Therapeutics Market Report Segments:
The global Asthma Therapeutics market is segmented on the basis of:
Types
Inhalation, Parenteral, Oral
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Boehringer Ingelheim
- F. Hoffmann-La Roche
- GSK
- Merck
- Horizon Pharma
- Mitsubishi Tanabe Pharma
- Sanofi
- Mundipharma
- Nycomed
- Kissei Pharmaceutical
- ALK-Abello
- Array BioPharma
- SAMA Pharmaceuticals
- Whanin Pharmaceutical
Highlights of The Asthma Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inhalation
- Parenteral
- Oral
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Asthma Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Asthma Therapeutics is a company that develops and manufactures asthma medications.
Some of the major companies in the asthma therapeutics market are AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck, Horizon Pharma, Mitsubishi Tanabe Pharma, Sanofi, Mundipharma, Nycomed, Kissei Pharmaceutical, ALK-Abello, Array BioPharma, SAMA Pharmaceuticals, Whanin Pharmaceutical.
The asthma therapeutics market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Asthma Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Asthma Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Asthma Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Asthma Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Asthma Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Asthma Therapeutics Market Size and Y-o-Y Growth
4.5.2 Asthma Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Asthma Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Asthma Therapeutics Market Size Forecast by Type
5.2.1 Inhalation
5.2.2 Parenteral
5.2.3 Oral
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Asthma Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Asthma Therapeutics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Asthma Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Asthma Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Asthma Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Asthma Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Asthma Therapeutics Market Size Forecast by Type
9.6.1 Inhalation
9.6.2 Parenteral
9.6.3 Oral
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Asthma Therapeutics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Asthma Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Asthma Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Asthma Therapeutics Market Size Forecast by Type
10.6.1 Inhalation
10.6.2 Parenteral
10.6.3 Oral
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Asthma Therapeutics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Asthma Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Asthma Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Asthma Therapeutics Market Size Forecast by Type
11.6.1 Inhalation
11.6.2 Parenteral
11.6.3 Oral
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Asthma Therapeutics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Asthma Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Asthma Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Asthma Therapeutics Market Size Forecast by Type
12.6.1 Inhalation
12.6.2 Parenteral
12.6.3 Oral
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Asthma Therapeutics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Asthma Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Asthma Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Asthma Therapeutics Market Size Forecast by Type
13.6.1 Inhalation
13.6.2 Parenteral
13.6.3 Oral
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Asthma Therapeutics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Asthma Therapeutics Market: Competitive Dashboard
14.2 Global Asthma Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Boehringer Ingelheim
14.3.3 F. Hoffmann-La Roche
14.3.4 GSK
14.3.5 Merck
14.3.6 Horizon Pharma
14.3.7 Mitsubishi Tanabe Pharma
14.3.8 Sanofi
14.3.9 Mundipharma
14.3.10 Nycomed
14.3.11 Kissei Pharmaceutical
14.3.12 ALK-Abello
14.3.13 Array BioPharma
14.3.14 SAMA Pharmaceuticals
14.3.15 Whanin Pharmaceutical
